Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections

NCT01142934 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

Catheterization
Infection

Interventions

DEVICE: Transparent adhesive dressing with an integrated gel pad containing 2% w/w chlorhexidine gluconate (CHG) (TegaDerm CHG)

Sponsor

Catholic University of the Sacred Heart

Collaborators

[object Object]
[object Object]